Your session is about to expire
← Back to Search
Omega-3 Fatty Acids
Omega-3 Supplements for Cardiovascular Disease (FAS Trial)
N/A
Waitlist Available
Led By Marie-Claude Vohl, Ph.D.
Research Sponsored by Laval University
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial Must have
Healthy men and women aged between 18 to 50 years
Free of any thyroid or metabolic disorders requiring treatment such as diabetes, hypertension, severe dyslipidemia, and coronary heart disease
Timeline
Screening 3 weeks
Treatment Varies
Follow Up up to 5 years
Awards & highlights
No Placebo-Only Group
Summary
This trial looks at the effects of a type of fish oil on metabolic risk factors, and whether individual genetic variation affects those results.
Who is the study for?
This trial is for healthy adults aged 18-50 with a BMI of 25-40kg/m2 and normal triglyceride levels. Participants should not smoke, drink alcohol regularly, or have thyroid/metabolic disorders like diabetes or severe dyslipidemia. Pregnant/nursing women and those on certain medications are excluded.
What is being tested?
The study is testing the effects of n-3 PUFA (Omega-3 fatty acid) supplements on metabolic risk factors related to cardiovascular disease, considering genetic variations that might affect how individuals respond to these fats.
What are the potential side effects?
While specific side effects aren't listed, Omega-3 supplements may sometimes cause mild digestive issues, fishy aftertaste, and increased bleeding tendency in some people.
Eligibility Criteria
Inclusion Criteria
You may be eligible if you check “Yes” for the criteria belowSelect...
I am between 18 and 50 years old and healthy.
Select...
I do not have diabetes, high blood pressure, severe cholesterol issues, or heart disease.
Timeline
Screening ~ 3 weeks3 visits
Treatment ~ Varies
Follow Up ~ up to 5 years
Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~up to 5 years
Treatment Details
Awards & Highlights
No Placebo-Only Group
All patients enrolled in this study will receive some form of active treatment.
Trial Design
1Treatment groups
Experimental Treatment
Group I: capsules omega-3Experimental Treatment1 Intervention
Omega-3 supplementation (3g EPA+DHA/d)
Find a Location
Who is running the clinical trial?
Laval UniversityLead Sponsor
434 Previous Clinical Trials
178,341 Total Patients Enrolled
Marie-Claude Vohl, Ph.D.Principal InvestigatorInstitute of Nutraceutical and Functional Foods (INAF), Laval University
Media Library
Eligibility Criteria:
This trial includes the following eligibility criteria:- I am on medication for high cholesterol, high blood pressure, diabetes, or I take blood thinners or omega-3 supplements.I am between 18 and 50 years old and healthy.My BMI is between 25 and 40.I do not have diabetes, high blood pressure, severe cholesterol issues, or heart disease.
Research Study Groups:
This trial has the following groups:- Group 1: capsules omega-3
Awards:
This trial has 1 awards, including:- No Placebo-Only Group - All patients enrolled in this study will receive some form of active treatment.
Timeline:
This trial has the following timeline:- Screening: It may take up to 3 Weeks to process to see if you qualify in this trial.
- Treatment: The duration you will receive the treatment varies.
- Follow Ups: You may be asked to continue sharing information regarding the trial for 6 Months after you stop receiving the treatment.